Factors that influence patient enrollment in active surveillance for low-risk prostate cancer

Michael A. Gorin, Cynthia T. Soloway, Ahmed Eldefrawy, Mark S. Soloway

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Objectives To learn from patients their rationale for enrollment in active surveillance (AS) for low-risk prostate cancer as an alternative to primary treatment. Methods A rank-order survey was designed to assess the relative influence of factors that contributed to the decision to elect AS. The survey was mailed to 185 patients enrolled in AS at our university-based urologic oncology practice. Participants were also asked whether they had been offered AS as an alternative to primary treatment by the urologist who had initially diagnosed their cancer. Results The survey was returned by 105 (57%) of 185 patients. AS was offered to 38 (36%) of 105 patients by the physician who had made the initial diagnosis. Patients most frequently reported physician influence as the greatest contributor to their decision to elect AS (73%). Patients also cited concerns regarding the potential side effects of incontinence (48%) and erectile dysfunction (44%) associated with therapy as reasons for choosing AS. Conclusions The results of the present study have shown that patients are heavily influenced by physicians in their decision to elect AS. Notably, the majority of our sampled patients were not offered AS at diagnosis. Evidence has indicated that AS is an appropriate approach for low-risk prostate cancer and should be discussed with patients in this risk category.

Original languageEnglish
Pages (from-to)588-591
Number of pages4
JournalUrology
Volume77
Issue number3
DOIs
StatePublished - Mar 1 2011
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Physicians
Erectile Dysfunction
Therapeutics
Surveys and Questionnaires
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. / Gorin, Michael A.; Soloway, Cynthia T.; Eldefrawy, Ahmed; Soloway, Mark S.

In: Urology, Vol. 77, No. 3, 01.03.2011, p. 588-591.

Research output: Contribution to journalArticle

Gorin, Michael A. ; Soloway, Cynthia T. ; Eldefrawy, Ahmed ; Soloway, Mark S. / Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. In: Urology. 2011 ; Vol. 77, No. 3. pp. 588-591.
@article{9dd1679fe6d748818e83644ca7c92187,
title = "Factors that influence patient enrollment in active surveillance for low-risk prostate cancer",
abstract = "Objectives To learn from patients their rationale for enrollment in active surveillance (AS) for low-risk prostate cancer as an alternative to primary treatment. Methods A rank-order survey was designed to assess the relative influence of factors that contributed to the decision to elect AS. The survey was mailed to 185 patients enrolled in AS at our university-based urologic oncology practice. Participants were also asked whether they had been offered AS as an alternative to primary treatment by the urologist who had initially diagnosed their cancer. Results The survey was returned by 105 (57{\%}) of 185 patients. AS was offered to 38 (36{\%}) of 105 patients by the physician who had made the initial diagnosis. Patients most frequently reported physician influence as the greatest contributor to their decision to elect AS (73{\%}). Patients also cited concerns regarding the potential side effects of incontinence (48{\%}) and erectile dysfunction (44{\%}) associated with therapy as reasons for choosing AS. Conclusions The results of the present study have shown that patients are heavily influenced by physicians in their decision to elect AS. Notably, the majority of our sampled patients were not offered AS at diagnosis. Evidence has indicated that AS is an appropriate approach for low-risk prostate cancer and should be discussed with patients in this risk category.",
author = "Gorin, {Michael A.} and Soloway, {Cynthia T.} and Ahmed Eldefrawy and Soloway, {Mark S.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1016/j.urology.2010.10.039",
language = "English",
volume = "77",
pages = "588--591",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Factors that influence patient enrollment in active surveillance for low-risk prostate cancer

AU - Gorin, Michael A.

AU - Soloway, Cynthia T.

AU - Eldefrawy, Ahmed

AU - Soloway, Mark S.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Objectives To learn from patients their rationale for enrollment in active surveillance (AS) for low-risk prostate cancer as an alternative to primary treatment. Methods A rank-order survey was designed to assess the relative influence of factors that contributed to the decision to elect AS. The survey was mailed to 185 patients enrolled in AS at our university-based urologic oncology practice. Participants were also asked whether they had been offered AS as an alternative to primary treatment by the urologist who had initially diagnosed their cancer. Results The survey was returned by 105 (57%) of 185 patients. AS was offered to 38 (36%) of 105 patients by the physician who had made the initial diagnosis. Patients most frequently reported physician influence as the greatest contributor to their decision to elect AS (73%). Patients also cited concerns regarding the potential side effects of incontinence (48%) and erectile dysfunction (44%) associated with therapy as reasons for choosing AS. Conclusions The results of the present study have shown that patients are heavily influenced by physicians in their decision to elect AS. Notably, the majority of our sampled patients were not offered AS at diagnosis. Evidence has indicated that AS is an appropriate approach for low-risk prostate cancer and should be discussed with patients in this risk category.

AB - Objectives To learn from patients their rationale for enrollment in active surveillance (AS) for low-risk prostate cancer as an alternative to primary treatment. Methods A rank-order survey was designed to assess the relative influence of factors that contributed to the decision to elect AS. The survey was mailed to 185 patients enrolled in AS at our university-based urologic oncology practice. Participants were also asked whether they had been offered AS as an alternative to primary treatment by the urologist who had initially diagnosed their cancer. Results The survey was returned by 105 (57%) of 185 patients. AS was offered to 38 (36%) of 105 patients by the physician who had made the initial diagnosis. Patients most frequently reported physician influence as the greatest contributor to their decision to elect AS (73%). Patients also cited concerns regarding the potential side effects of incontinence (48%) and erectile dysfunction (44%) associated with therapy as reasons for choosing AS. Conclusions The results of the present study have shown that patients are heavily influenced by physicians in their decision to elect AS. Notably, the majority of our sampled patients were not offered AS at diagnosis. Evidence has indicated that AS is an appropriate approach for low-risk prostate cancer and should be discussed with patients in this risk category.

UR - http://www.scopus.com/inward/record.url?scp=79952359225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952359225&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2010.10.039

DO - 10.1016/j.urology.2010.10.039

M3 - Article

C2 - 21215429

AN - SCOPUS:79952359225

VL - 77

SP - 588

EP - 591

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3

ER -